GCH1 in early-onset Parkinson's disease

Area of Science:

• Neurogenetics
• Movement Disorders

Background:

• Mutations in GTP-cyclohydrolase 1 (GCH1) cause dopa-responsive dystonia (DRD), often presenting with Parkinsonism.
• Dystonia is a common feature in early-onset Parkinson's disease (EOPD).
• The genetic overlap between DRD and EOPD, particularly concerning GCH1, requires investigation.

Purpose of the Study:

• To determine the frequency of GCH1 mutations in familial early-onset Parkinson's disease (EOPD).
• To assess the association between GCH1 genetic variability and EOPD susceptibility.
• To evaluate the role of PRKN, PINK1, and DJ-1 mutations in familial EOPD.

Main Methods:

• Sequencing of GCH1 coding regions and copy-number analysis in 53 familial EOPD patients.
• Screening for mutations in PRKN, PINK1, and DJ-1 in the same patient cohort.
• Association study of common GCH1 variants with EOPD risk in a matched patient-control series.

Main Results:

• No GCH1 coding mutations or copy-number abnormalities were found in familial EOPD patients.
• A novel GCH1 promoter deletion was identified in a small subset of patients and controls, with no significant association with EOPD.
• Homozygous or compound heterozygous PRKN mutations were identified in 26.4% of familial EOPD patients, associated with younger age of onset and higher dystonia prevalence.

Conclusions:

• Genetic variations in GCH1 do not play a significant role in the etiology of early-onset Parkinson's disease.
• The study underscores the importance of PRKN gene screening in the diagnostic workup of familial EOPD.
• Further research into the genetic underpinnings of EOPD, beyond GCH1, is warranted.